American Specialty Health, Incorporated (ASH) is the nation's largest organization for complementary health care benefit programs, health education programs, and health products. ASH and its affiliates contract with 60 health plans nationwide and provide benefit programs to 12.1 million members. Based in San Diego, ASH has 500 employees. www.ashcompanies.com

Boehringer Ingelheim Pharmaceuticals, Inc. is the largest privately owned pharmaceutical company in the world. Boehringer Ingelheim's primary pharmaceutical products treat HIV/AIDs, central nervous system, pulmonary, respiratory, cardiovascular, cerebrovascular, and urological health problems. The Boehringer Ingelheim Corporation is committed to providing products that significantly enhance health and quality of life. For more information please visit http://www.boehringer-ingelheim.com/corporate/home/home.asp

CorSolutions is the nation’s first customer-centric health intelligence and solutions company that measurably improves lives. An industry pioneer with the longest tenure of healthcare outcomes, CorSolutions offers an innovative, comprehensive approach to health and productivity through a completely integrated suite of clinical, administrative and provider services over the entire health continuum.

Those we educate and support stay healthier, do better and enjoy a higher quality of life. And we’re verifying those improvements in quantifiable ways. www.corsolutions.com

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms, and their respective subsidiaries and affiliates. Deloitte Touche Tohmatsu is an organization of member firms around the world devoted to excellence in providing professional services and advice, focused on client service through a global strategy executed locally in nearly 150 countries. With access to the deep intellectual capital of 120,000 people worldwide, Deloitte delivers services in four professional areas — audit, tax, consulting, and financial advisory services — and serves more than one-half of the world’s largest companies, as well as large national enterprises, public institutions, locally important clients, and successful, fast-growing global growth companies. Services are not provided by the Deloitte Touche Tohmatsu Verein, and, for regulatory and other reasons, certain member firms do not provide services in all four professional areas.

For more than 29 years, Genentech has been at the forefront of the biotechnology industry, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech manufactures and commercializes multiple biotechnology products that have helped patients suffering from serious diseases and conditions, including breast cancer, colon cancer, lung cancer, non-Hodgkin's lymphoma, cystic fibrosis, heart attack, stroke, growth hormone deficiency, psoriasis, and asthma. The company is the leading provider of anti-tumor therapeutics in the United States. Genentech has a history of groundbreaking science, and the company invests heavily in research and development.
www.gene.com

GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.

GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.

Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. www.gsk.com/index.htm

Founded in 1983, Health Management Corporation (HMC) is a leading health and disease management company addressing chronic and complex health conditions. Through clinical interventions, innovative technology and advanced predictive models, HMC helps health plans and employers increase self care, improve clinical outcomes and control overall costs. HMC’s unique clinical structure includes assigned primary nurse care managers, who develop Individualized Intervention PlansSM (IIP) to address participants’ overall health. For more information, call 800-523-9279 or visit www.choosehmc.com

The trusted source for Population Health and Care Support for nearly 2 million people nationwide. Our Health and Care Support programs Health Risk Screening and Support, Condition Management and Advanced Care Support address 100% of the population improving lives and lowering costs for health plans, the government and employers. For more information, visit www.healthways.com.

With a unique combination of actuarial and business expertise, Milliman consultants go beyond the numbers to the implications, beyond the reports to the applications. We draw from our enormous knowledge and experience base to bring depth, clarity and context to the issues you're facing. In short, we deliver insight. Insight into your business, your markets, your challenges - and the answers that will help you succeed. www.milliman.com

As one of the world’s leading healthcare companies, Pfizer Inc has developed and brought to market medicines for humans and animals for over 150 years. Our portfolio includes more category-leading medicines than any other company – treatments that are helping countless people everyday to ease arthritis and nerve pain, manage depression, fight diabetes and cancer and control hypertension– and we are targeting unmet medical needs through state-of-the-art research and development. With over 400 projects in our discovery pipeline and the largest library of chemical compounds in the industry, Pfizer expects to continue discovering new medicines and cures that will help people around the world enjoy longer, healthier, and more productive lives. Visit us at www.pfizer.com

The sanofi-aventis Group is the world's 3rd largest pharmaceutical company, ranking number 1 in Europe. Backed by a world-class R&D; organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic disorders, central nervous system, internal medicine and vaccines. The sanofi-aventis Group is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY). Company Website: www.sanofi-aventis.com

At the New Schering-Plough, we aspire to earn the trust of doctors, patients and customers by providing a steady flow of innovative, science-based medicines and services that improve the health and well-being of people around the world.

To achieve these goals we are working to earn the trust of all stakeholders. We understand that earning trust demands hard work, sharp execution, integrity and transparency. For more information please visit www.Schering-Plough.com